Acute Myeloid Leukemia (AML) – AML Leukemia [Updated]

Treatment of Acute Myeloid Leukemia (AML)

In some cases, the diagnosis of AML represents a very high number of leukemic cells in the patient’s blood, which can cause severe circulatory problems, along with a number of neurological symptoms and, in some cases, complete respiratory or even circulatory collapse.

As explained before, AML is a complex disease with different clinical forms and subtypes, which represent different prognoses and highly variable responses to treatment.

Therefore, the treatment options available to each patient are based on the identification of the specific leukemia subtype, which can be done through a number of laboratory tests, and the interpretation of the individual’s prognostic characteristics or factors.

Several types of treatment can be used to treat people with AML. However, all of them focus on the effective elimination of leukemia cells, damaging as little as possible the normal cells of the bone marrow and other tissues of the patient.

Some of the most common avenues of treatment include:

• Chemotherapy

• Bone Marrow Transplant

• Allogeneic Stem Cell Transplant